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Background: Many patients with various types of colonic pathology undergo invasive procedures that
require mechanical bowel preparation. The most commonly used medications for bowel preparation
include phosphate-containing drugs which are low cost and enable this procedure to be performed in an
outpatient setting, as opposed to other medications, such as polyethylene glycol. Recent studies have
suggested that freely using phosphate-containing drugs might lead to renal function impairment in
a small group of patients. Despite this, many surgeons still use these drugs to prepare their patients. We
conducted a comparative study to check the side effects of phosphate-containing drugs compared to
polyethylene glycol when used for bowel cleansing.
Methods: We conducted a double blind prospective randomized study that included 40 patients
undergoing surgery for colonic pathology, all of whom underwent bowel cleansing (20 with sodium
phosphate and 20 with polyethylene glycol). During the perioperative course, electrolyte parameters
were collected from serum and urine and compared between the two groups of patients.
Results: Changes in electrolyte and metabolic parameters were shown in both groups, but more prom-
inently in patients prepared with sodium phosphate. In addition, early signs of renal function impair-
ment appeared in this group. The differences in metabolic and electrolyte changes between the two
groups were statistically signiﬁcant.
Conclusions: On the basis of this study, we propose that the wide use of phosphate-containing drugs for
colonic preparation might be dangerous for the speciﬁc group of patients that is prone to develop renal
failure or electrolyte abnormalities.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Diseases of the colon and rectum, mainly cancer and diverticular
disease, are one of the most common reasons for elective and
urgent admissions to a surgical ward. All these patients will require
mechanical bowel preparation prior to the endoscopic procedures
and surgical intervention.
The most commonly used preparations for bowel preparation
include phosphate-containing drugs and polyethylene glycol.
Some studies found that the use of phosphate-containing drugs
for bowel preparation is related to a higher risk of complications
such as electrolyte and metabolic disturbances or disorders.1e10
Other publications even raised the question of a higher leakage
rate in patients prepared by phosphate-containing drugs asx: þ972 89779225.
vy).
ciates Ltd. Published by Elsevier Ltcompared to patients who do not undergo mechanical preparation
at all.11e13 However, a recentmeta-analysis published by Slim et al.14
did not conﬁrm this point. As the majority of surgeons performing
colorectal surgeryprepare theirpatientsprior to surgery,wedecided
to see if bowel preparationwithotherdrugswouldbe less harmful to
the patient than the use of phosphate-containing drugs.
We conducted a double blind prospective randomized study to
check the rate and severity of electrolyte and metabolic distur-
bances in patients undergoing mechanical bowel preparation by
phosphate-containing medication [Soffodex: (Dexon Ltd, Or Hakiva
P.O.B 50, 38100, Israel)], as compared to patients using poly-
ethylene glycol [Meroken solution: (Taro Pharmaceutical Industries
ltd, POB 10347 Haifa Bay, 26110, Israel)].
2. Patients and methods
Forty patients scheduled for elective colonic surgery (divertic-
ular disease and cancer) were randomly assigned to boweld. All rights reserved.
Table 1
Comparison of mean changes (D) of serum electrolyte levels in the two groups before and following bowel preparation.
Soffodex group Meroken group p-value
Mean serum level changes (D) CI 90% Range Mean serum level changes (D) CI 90% Range
Phosphorus 0.95 0.536 mg/dL 0.19 0.76 to 1.14 0.15  0.24 mg/dL 0.09 0.1 to 0.08 <0.001
Calcium 0.83 0.377 mg/dL 0.14 0.97 to 0.69 0.055  0.298 mg/dL 0.11 0.06 to 0.16 <0.001
Magnesium 0.565  0.27 mg/dL 0.1 0.66 to 0.46 0.095  0.24 mg/dL 0.09 0.18 to 0.00 <0.001
Sodium 4.195  0.1 mmol/L 1.14 3.06 to 5.34 2.25  4.05 mmol/L 1.49 0.76 to 3.74 <0.038
Osmolarity 6. 95  4.76 mosmol/dL 1.75 5.2 to 8.7 0.05  2.25 mosmol/dL 0.83 0.78 to 0.88 <0.001
Potassium 0.61  0.458 mmol/L 0.17 0.78 to 0.44 0.275  0.162 mmol/L 0.06 0.33 to 0.21 ¼0.01
D ¼ mean serum level changes before and following bowel preparation.
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polyethylene glycol (Group Be 20 patients). Patients were assigned
to Group A or B according to admission order (Group A the ﬁrst
patient, Group B the second patient, and so on and so forth). If
a patient scheduled for one of the groups was excluded, then the
next patient was entered in his place.
The experimental protocols were approved by the appropriate
Institutional Review Board of the hospital and all patients signed an
informed consent as requested by the Institutional Review Board.
Each 5 ml of sodium phosphate contains 2.4 g sodium dihy-
drogen phosphate H2O, 0.9 g sodium hydrogen phosphate 7H20 and
0.65 g Sodium. The patients were prepared by two vials of 40 ml
each. The preparation began at 2 pmwith the ﬁrst vial followed by
a second vial at 5 pm. The patients were instructed to drink ad
libidum.
Polyethylene glycol is a solution based on polyethylene glycol
315 g, sodium chloride 8.42 g, sodium bicarbonate 4.28 g and
potassium chloride 1.1175 g diluted in 2700 ml of water. The
preparation began at 2 pm and had to be completed within 4 h. The
patients were instructed to drink ad libidum.
Blood tests including serum sodium, potassium, calcium,
phosphorus, magnesium, blood gases, serum creatinine levels,
serum osmolarity and creatinine clearance were taken before
preparation was initiated. The same blood tests were taken
immediately following bowel preparation. Twenty-four hour urine
output was collected and electrolyte secretion measured. The
results of the blood tests and urine collection were compared in
each Group before and after colonic preparation, and the overall
results of Group Awere compared to Group B. Exclusion criteria for
entry to this study were creatinine levels above 1.5 g/dL and serum
potassium levels above 5.5 mmol/dL.
All checked parameters and their mean changes were compared
between the two Groups. Statistical analysis was performed at the
Department of Statistics of Tel-Aviv University using EXCEL and
SPSS programs.
This study was part of the Israel Medical Council basic science
requirement for completion of residency in general surgery.
3. Results
Both Groups were comparable with regard to sex and age; the
mean age being 62.5 years for Group A and 61.5 years for Group B.
The baseline blood tests and urine analysis were similar in both
Groups, but both Groups exhibited electrolyte and metabolicTable 2
Inﬂuence of mechanical bowel preparation on acid-base balance.
Soffodex group
Mean serum level changes (D) CI 90% Range
Serum pH 0.074  0.031 0.01 0.08 to 0.06
Base excess 3.625  1.67 mmol/L 0.61 0.33 to 0.21
D ¼ mean serum level changes before and following bowel preparation.changes to a certain degree following bowel preparation, these
being much more signiﬁcant in Group A.
The mean potassium base levels were 4.1 mmol/L for Group A
and 4.1 mmol/l for Group B. Following bowel preparation these
decreased to 3.4 mmol/L in Group A compared to 3.8 mmol/l Group
B (normal range in our laboratory is 3.5e5.5 mmol/L).
The meanmagnesium baseline levels were 2.4 mg/dl in Group A
and 2.2 mg/dl in Group B. Magnesium levels decreased to 1.8 mg/dl
in Group A, but remained almost the same in Group B and only
decreased to 2.1 mg/dl (normal range 1.7e2.9 mg/dl).
The mean baseline phosphorus level was 3.5 mg/dl in Group A
and 3 in Group B. While in Group B the mean phosphorus level did
not change following bowel preparation, the levels increased in
Group A to 4.6 mg/dl (our normal laboratory range is 2.5e4.1 mg/
dl).
Mean baseline calcium levels were 9.4 mg/dl in Group A and
8.8 mg/dl in Group B. After the preparation, the mean calcium level
in Group A slightly decreased to 8.8 mg/dl while in Group B it
remained unchanged (normal range for serum calcium in our
laboratory is 8.5e10.5 mg/dl).
Mean baseline serum sodium levels were 138.0 mmol/l for
Group A and 138.1 mmol/l for Group B. Following bowel
preparation, mean sodium levels rose to 142 mmol/l in Group A
and to only 139 mmol/l in Group B (normal range
135e145 mmol/l).
Statistically signiﬁcant changes in acid-base balance parameters
were shown in both groups following bowel preparation e
decreased pH levels and depression of base excess: mean pH
decreased from 7.39 to 7.31 in Group A and from 7.39 to 7.36 in
Group B. However, a more severe metabolic acidosis developed in
Group A than in Group B.
Impairment in renal function was shown in Group A where
serum creatinine levels increased from 0.8 mg/dl at baseline to
1 mg/dl at the end of bowel preparation, while in Group B serum
creatinine levels remained at the same level of 0.8 mg/dl before
and after bowel preparation (normal range in our laboratory
<1.1 mg/dl).
Creatinine clearance time (CCT) dropped more prominently in
Group A: from 190 before to 100 following colon cleansing
compared to Group B where the CCT rate decreased from 140 to120
before and after colon preparation, respectively.
Allparameterschecked inbothgroupsandtheirmeanchangeswere
compared between the two groups and showed statistically signiﬁcant
differences that were more prominent in Group A (Tables 1e3).Meroken group p-value
Mean serum level changes (D) CI 90% Range
0.0185  0.036 0.01 0.03 to 0.01 <0.001
0.585  0.296 mmol/L 0.11 4.24 to 3.01 <0.001
Table 3
Renal function parameters inﬂuenced by Soffodex versus Meroken.
Soffodex group Meroken group p-value
Mean serum level changes (D) CI 90% Range Mean serum level changes (D) CI 90% Range
Creatinine 0.22  0.19 mg/dL 0.07 0.15 to 0.29 0.04  0.14 mg/dL 0.05 0.01 to 0.09 <0.009
Creatinine clearance time 93.24  93.604 34.3 127.6 to 58.8 23.91  74.7 27.4 51.3 to 3.58 <0.001
D ¼ mean serum level changes before and following bowel preparation.
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It was the observation of our anesthesiologists that patients
undergoing mechanical bowel preparation by sodium phosphate
developed metabolic acidosis.
We assumed that the effect of sodium phosphate on the elec-
trolyte and acid-base balance was to be blamed. Before embarking
on a different protocol of bowel preparation using a different drug
(polyethylene glycol), we decided to study the metabolic effects of
these preparations in a double blind prospective study.
The two groups studied by us were comparable for age, sex and
underlyingpathology. Reviewingour results it becomes clear that the
electrolyte and metabolic changes were more pronounced in the
groupof patients preparedbyphosphate containing solutions (Group
A e sodium phosphate) when compared to Group B (polyethylene
glycol). These differences reached a statistical signiﬁcance for serum
osmolarity and serum calcium and magnesium levels (Table 1).
Moreover, statistically signiﬁcant changes were also shown for acid-
base balance: serum pH levels and base excess (Table 2). Renal
function impairment was also of statistical signiﬁcance regarding
CCT. While serum creatinine levels showed functional derangement
in Group A, this difference was of no statistical signiﬁcance (Table 3).
Although changes were noticed in serum sodium and potassium
levels, these changes did not reach statistical signiﬁcance.
The subject of bowel preparation and the possible electrolyte
andmetabolic derangement caused by the solution used, has raised
a lot of interest and as result the publication of many articles.1e7,15,16
Sodium phosphate, as a phosphate-based solution, is known to
provoke metabolic and electrolyte derangement as shown in many
studies.1e4,15 Moreover, Markowitz et al.6 raised concerns that
bowel preparation might provoke renal failure due to the devel-
opment of nephrocalcinosis.
The majority of the studies discussed are retrospective. To the
best of our knowledge, there is only one other prospective study
comparing sodium phosphate and polyethylene glycol.17 Recently,
some studies reported on colonic surgery without bowel prepara-
tion, showing that this approach is followed by a rate of compli-
cations that is comparable with that for patients receiving bowel
preparation.10e14 Moreover, in some series a lower rate of leakage
was shown when compared to patients receiving bowel prepara-
tion, raising a concern that bowel preparation with its intracellular
changes can predispose to leaks.10
However, since themajority of surgeons still prepare their patients
prior to colorectal surgery, we believe that the choice of the least
harmful solution for bowel preparation is of the utmost importance.
Our study clearly shows amore severe electrolyte andmetabolic
derangement in patients prepared by phosphate containing solu-
tions as compared to the patients prepared by polyethylene glycol.
Elderly and dehydrated patients may be more prone to develop
these changes. The hyperphosphatemia is probably induced by the
phosphate overdose, although the compensatory hypocalcaemia
was of no clinical signiﬁcance. Other disturbances such as
decreased magnesium and potassium levels as well as increased
serum osmolarity and sodium levels might be secondary to the
osmotic diarrhea effect of sodium phosphate. The derangement in
CCT in Group A should raise a note of caution for bowel preparationin patients prone to develop renal failure. Thus patients receiving
bowel preparation by phosphate-containing drugs need close
follow up and monitoring of electrolyte and acid-base balance.
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